{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:25:56Z","timestamp":1761744356896},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.gyobfe.2016.04.010","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T09:08:57Z","timestamp":1464167337000},"page":"345-349","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Peut-on proposer un pr\u00e9l\u00e8vement du ganglion sentinelle en cas de chimioth\u00e9rapie n\u00e9oadjuvante dans les cancers du sein et \u00e0 quel moment\u00a0?"],"prefix":"10.1016","volume":"44","author":[{"given":"C.","family":"Coutant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Portha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Barranger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gyobfe.2016.04.010_bib0165","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1200\/JCO.2001.19.22.4224","article-title":"Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902","volume":"19","author":"van der Hage","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0170","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/cncr.20298","article-title":"Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26\u201328, 2003, Philadelphia, Pennsylvania","volume":"100","author":"Schwartz","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0175","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/cncr.20491","article-title":"Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors","volume":"101","author":"Rouzier","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0180","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jnci\/dji021","article-title":"Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis","volume":"97","author":"Mauri","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0185","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/bjs.5894","article-title":"Neoadjuvant chemotherapy for operable breast cancer","volume":"94","author":"Mieog","year":"2007","journal-title":"Br J Surg"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0190","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.jncimonographs.a003469","article-title":"Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18","author":"Wolmark","year":"2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0195","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.2008.19.2567","article-title":"Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer","volume":"27","author":"Gianni","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0200","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1200\/JCO.2003.12.005","article-title":"The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"21","author":"Bear","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0205","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32\u00a0randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.amjsurg.2007.08.068","article-title":"Sentinel node mapping performed before preoperative chemotherapy may avoid axillary dissection in breast cancer patients with negative or micrometastatic sentinel nodes","volume":"196","author":"Schrenk","year":"2008","journal-title":"Am J Surg"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0215","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ejso.2008.11.002","article-title":"Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy","volume":"35","author":"Menard","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0220","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jso.21128","article-title":"Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer","volume":"98","author":"Papa","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0225","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ejca.2015.03.014","article-title":"Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: identification rate and influence on axillary treatment","volume":"51","author":"van der Heiden-van der Loo","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0230","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0235","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"32","author":"Lyman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0240","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejso.2006.09.032","article-title":"Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer","volume":"33","author":"Lanng","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0245","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.gyobfe.2015.04.007","article-title":"Evaluation of axillary involvement by ultrasound-guided lymph node biopsy: a prospective study","volume":"43","author":"Jankowski","year":"2015","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0250","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SLA.0b013e31821f1564","article-title":"Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla","volume":"254","author":"Houssami","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0255","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"23","author":"Mamounas","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0260","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimioth\u00e9rapie N\u00e9oadjuvante, a French prospective multicentric study","volume":"27","author":"Classe","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0265","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.5209","article-title":"Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer","volume":"93","author":"Xing","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0270","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.acra.2009.01.026","article-title":"Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta-analysis","volume":"16","author":"Kelly","year":"2009","journal-title":"Acad Radiol"},{"issue":"2","key":"10.1016\/j.gyobfe.2016.04.010_bib0275","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ijc.29644","article-title":"Sentinel node biopsy performance after neoadjuvant chemotherapy in locally advanced breast cancer: a systematic review and meta-analysis","volume":"138","author":"Mocellin","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0280","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0285","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1470-2045(14)70080-4","article-title":"Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort","volume":"15","author":"Gianni","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","article-title":"Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2\u00a0trial","volume":"13","author":"Gianni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0295","doi-asserted-by":"crossref","first-page":"e105316","DOI":"10.1371\/journal.pone.0105316","article-title":"Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis","volume":"9","author":"Fu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0300","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0305","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0310","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0315","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4,N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.gyobfe.2016.04.010_bib0160","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/his.12853","article-title":"Sentinel lymph nodes for breast carcinoma: an update on current practice","volume":"68","author":"Maguire","year":"2016","journal-title":"Histopathology"},{"issue":"18","key":"10.1016\/j.gyobfe.2016.04.010_bib0320","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.ejca.2009.08.001","article-title":"Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review","volume":"45","author":"van Deurzen","year":"2009","journal-title":"Eur J Cancer"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958916301059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958916301059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T11:18:50Z","timestamp":1656587930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958916301059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1297958916301059"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2016.04.010","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peut-on proposer un pr\u00e9l\u00e8vement du ganglion sentinelle en cas de chimioth\u00e9rapie n\u00e9oadjuvante dans les cancers du sein et \u00e0 quel moment\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gyobfe.2016.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.gyobfe.2016.04.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}